On April 23, 2009, the United States District Court for the District of Vermont dealt another blow to pharmaceutical manufacturers and the data mining companies that sell prescriber-identifiable data to them by upholding a Vermont law prohibiting various entities from selling or using such data for marketing purposes without prescriber consent. IMS Health Inc. v. Sorrell, No. 07-cv-188 (D. Vt. Apr. 23, 2009). The ruling follows the recent ruling by the U.S. Court of Appeals for the First Circuit upholding a similar New Hampshire law.

Please see full advisory for more information.